Radiation Oncologist. Views my own.
Joined March 2008
- Tweets115
- Following87
- Followers202
- Likes623
5th molecular class?! ER negative NSMPs associated with a poorer prognosis similar to p53 mutated endometrial cancers #ESMOGynae24 #gyncsm
Adeline Lim retweeted
#ABG2024 Hobart @sylviahanna18 and colleagues representing @ONJCancerCentre novel techniques, brachy training, using MRI-sim. Exemplary work. @CarminiaLapuz @adelinelim
Adeline Lim retweeted
Published today: ascopubs.org/doi/pdfdirect/1…
🧵2/ Metastasis-directed Tx to the 🫁 has limited trial evidence (surgery or SABR). Whilst convenient, popular during #COVID19, there is reluctance for single fraction fraction 🥊 SABR for perceived toxicity. @TROGfightcancer SAFRON II randomised n=90 with 133 🫁 mets to 1 vs 4fx SABR
Adeline Lim retweeted
Dr Mercier late-breaking #ESTRO2023 - !!!BLINDED!!! RCT of #radiotherapy for painful bone Mets,
➡️single 8Gy 3DCRT versus SABR 20Gy. ⬆️ complete pain response 54% versus 33% at 3 months with SABR, but not 1 month. Higher rates of re-irradiation in conv RT arm. #radonc
Adeline Lim retweeted
Safety analysis of Northstar trial: Phase II Randomized Study of Osimertinib With or Without Local Consolidative Therapy (LCT) for Metastatic EGFR Mutant NSCLC
👉 excellent safety of surgery & radiotherapy
👉 RT numerically lower tox despite no interruption of Osi in most pts
Excluding people with disabilities from becoming doctors “reductionist thinking that does a disservice to our profession”. What an impressive and eye-opening session. #racma2022
Dr Dinesh Palipana, Doctors With Disability says "we need to think about the communities we serve. 1 in 5 people have a disability. If we are doing the same thing we always have we are not going to go forward." RACMA 2022 - Equity and Access, Healthcare For All #racma2022
Adeline Lim retweeted
Wow! Sublobar resection (including wedge) are equivalent to lobectomy for stage I lung cancer <2cm. No difference in DFS or OS and similar rates of recurrence. #WCLC22
Likely new standard of care!
Slowly getting there with regards to SRS for brain mets in patients with small cell lung cancer
Practice changing work led by @SunnyD_UT adding evidence to support SRS for small cell lung cancer brain mets. Congrats and thanks for building a great team and for @Sunnybrook to participate. sciencedirect.com/science/ar…
Adeline Lim retweeted
Delighted to share our systematic review of heart dose
- More stringent IMRT❤️sparing planning objectives needed
- Consensus on contouring and Dose Volume Constraints is lacking
- Dose parameters reported for substructures vary substantially
pubmed.ncbi.nlm.nih.gov/3557…
Great study @leunger22 - would be a game changer. Am assuming you wouldn’t be doing this with concurrent chemo à la PORTEC-3, so patient population might end up being different to those in your study? #gyncsm
Can the number of radiation treatments to the pelvis for uterus cancer patients be decreased from 25 down to 5? See our recent publication in JAMA Oncology - The SPARTACUS trial. #radonc #GynCSM @Sunnybrook @LHSCCanada jamanetwork.com/journals/jam…
Excellent dosimetry made possible by #3Dprinted applicators - could they be in our future @sylviahanna18 @CarminiaLapuz @NikkiShelton003? @ONJCancerCentre #gyncsm #ThisisBrachytherapy #abg002
Fascinating talk by @petric_primoz discussing #MR pre-planning for optimal gyn #brachy implant and #3Dprinting applications - innovations session #ABG22. @ausbrachy #gyncsm @sylviahanna18 @adelinelim @sylvia_vandyk
Adeline Lim retweeted
Post-hoc analysis of immune-mediated adverse events with durvalumab from PACIFIC in @LungCaJournal. Usually occur in 1st 3m. Most common were pneumonitis and thyroid dysfunction. G3+ were uncommon. Reassuring report led by Dr. @DrJNaidoo et al. #LCSM
lungcancerjournal.info/artic…
Fascinating talk on brachytherapy for paediatric malignancies. Incredible work! #abg2022 #paediatricbrachy @AusBrachy @CarminiaLapuz @sylviahanna18 @sylvia_vandyk @drjchard @saratchanderRO @JPoderMedPhys
6 weekly source changes! #livingthedream #abg2022 #liverbrachy @stef_corradini @sylviahanna18 @CarminiaLapuz @sylvia_vandyk
So excited to attend this year’s Australian Brachytherapy Group’s ASM - very much looking forward to learning from the combined wealth of knowledge from the excellent speakers! @AusBrachy
3 days to go!!!
There is still time to register to what is promised to be an inspiring program.
Register now abg2022.com
@adelinelim @CarminiaLapuz @sylvia_vandyk @Elekta_ANZ @JPoderMedPhys @drjchard @andrejbece @AusBrachy @CathBeaufort @AmericanBrachy @ESTRO_RT
A fantastic opportunity to shape the future - and a great place to work!
Are you a Radiation Therapist who’s passionate about research and helping others to do the same? Our newly established Senior Research Radiation Therapist role could be for you 👇 seek.com.au/Job/55245894/?ci…
Lung ART - no benefit in the use of PORT in patients with resected N2 disease. Would be interesting to see a subset analysis of those with ECE #lungcancer
Online first: phase 3 Lung ART trial - #postoperative #radiotherapy (#PORT) vs no PORT in patients with completely resected #NSCLC & proven mediastinal N2 involvement
#lungcancer #lcsm
thelancet.com/journals/lanon…
Join us at the Australasian Brachytherapy Group’s ASM in 2022 - we are lucky to have multiple fantastic speakers and it promises to be an excellent programme! #ABG2022
Only 2 weeks remaining to score the earlybird rate for our 2022 annual meeting #ABG2022. The online meeting will have a program suitable for time zones all over the world. Follow the link below to register!
abg2022.com/
